Cooper C. Collins Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Cooper C. Collins.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Cooper C. Collins. Cooper C. Collins is a Director in TherapeuticsMD, Inc. ($COFF) and a President and CEO in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA).

Address: 33219 FOREST WEST DRIVE MAGNOLIA 77354 TX

Companies in which Cooper C. Collins is an Insider

PERNIX THERAPEUTICS HOLDINGS, INC.

Trading Symbol: GTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cooper C. Collins: President and CEO
Holdings: 9,405,000 shares
Latest Transaction: Mar 11 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TherapeuticsMD, Inc.

Trading Symbol: TXMD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cooper C. Collins: Director
Holdings: 92,500 shares
Latest Transaction: Jun 19 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Cooper C. Collins

Sentiment: All, GTA, TXMD

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2020TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorOption ExerciseA0.0096,864096,864
Jun 10 2020TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorBuyP1.4547,50068,875140,00092.5 K to 140 K (+51.35 %)
Jun 10 2020TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorBuyP1.4526,50038,42592,50066 K to 92.5 K (+40.15 %)
Jun 24 2019TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorOption ExerciseA2.6475,000198,00075,000
May 15 2019TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorBuyP3.3330,00099,87066,00036 K to 66 K (+83.33 %)
Jul 05 2018TXMDTherapeuticsMD, In ...Collins Cooper C.DirectorOption ExerciseA6.3550,000317,50050,000
Jun 23 2017COFFTherapeuticsMD, In ...Collins Cooper C.DirectorOption ExerciseA5.8050,000290,00050,000

View all Cooper C. Collins insider transactions.